Use of intraperitoneal interferon α-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial
- 31 October 2002
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 78 (4) , 705-711
- https://doi.org/10.1016/s0015-0282(02)03330-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Medical management of endometriosisInternational Journal of Gynecology & Obstetrics, 2000
- Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon- α-2b in a murine modelFertility and Sterility, 1999
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996Fertility and Sterility, 1997
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Individual and combined effects of triptoreline and gestrinone on experimental endometriosis in ratsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- The Suppression of Peritoneal Cellular Immunity in Women With Endometriosis Could Be Restored After Gonadotropin Releasing Hormone Agonist TreatmentAmerican Journal of Reproductive Immunology, 1996
- Postsurgical medical treatment of advanced endometriosis: Results of a randomized clinical trialAmerican Journal of Obstetrics and Gynecology, 1994
- Recombinant Interleukin‐2 Corrects In Vitro the Immunological Defect of EndometriosisAmerican Journal of Reproductive Immunology, 1993
- EndometriosisInternational Journal of Gynecology & Obstetrics, 1993
- Gonadotropin-releasing hormone analogs in the treatment of endometriomasAmerican Journal of Obstetrics and Gynecology, 1990